Nutra Pharma Return On Asset vs. Current Valuation
| NPHC Stock | USD 0.0001 0.00 0.00% |
For Nutra Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nutra Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nutra Pharma Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nutra Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nutra Pharma Corp over time as well as its relative position and ranking within its peers.
Nutra |
Nutra Pharma Corp Current Valuation vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nutra Pharma's current stock value. Our valuation model uses many indicators to compare Nutra Pharma value to that of its competitors to determine the firm's financial worth. Nutra Pharma Corp is considered to be number one stock in return on asset category among its peers. It also is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nutra Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nutra Pharma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nutra Current Valuation vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Nutra Pharma |
| = | -1.13 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Nutra Pharma |
| = | 10.33 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Nutra Current Valuation vs Competition
Nutra Pharma Corp is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 52.62 Million. Nutra Pharma retains roughly 10.33 Million in current valuation claiming about 20% of equities under Health Care industry.
Nutra Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nutra Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nutra Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Nutra Pharma's change in net profit over the period of time. It can combine multiple indicators of Nutra Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Nutra Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nutra Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nutra Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nutra Pharma's important profitability drivers and their relationship over time.
Use Nutra Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nutra Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutra Pharma will appreciate offsetting losses from the drop in the long position's value.Nutra Pharma Pair Trading
Nutra Pharma Corp Pair Trading Analysis
The ability to find closely correlated positions to Nutra Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nutra Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nutra Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nutra Pharma Corp to buy it.
The correlation of Nutra Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nutra Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nutra Pharma Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nutra Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nutra Pharma position
In addition to having Nutra Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run ESG Investing Thematic Idea Now
ESG Investing
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Nutra Pink Sheet
To fully project Nutra Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nutra Pharma Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nutra Pharma's income statement, its balance sheet, and the statement of cash flows.